Relevant bibliographies by topics / Translocation renal cell carcinoma

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Translocation renal cell carcinoma'

Author: Grafiati
Published: 11 March 2023
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Translocation renal cell carcinoma.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Translocation renal cell carcinoma"

1

Armah, Henry B., and Anil V. Parwani. "Xp11.2 Translocation Renal Cell Carcinoma." Archives of Pathology & Laboratory Medicine 134, no. 1 (2010): 124–29. http://dx.doi.org/10.5858/2008-0391-rsr.1.

Full text
Abstract:
Abstract Xp11.2 translocation renal cell carcinomas (RCCs), a recently recognized distinct subtype, are rare tumors predominantly reported in young patients. They comprise at least one-third of pediatric RCCs, and only few adult cases have been reported. They are characterized by various translocations involving chromosome Xp11.2, all resulting in gene fusions involving the transcription factor E3 (TFE3) gene. In recent years, at least 6 different Xp11.2 translocation RCCs have been identified and characterized at the molecular level. These include a distinctive RCC that bears a translocation
APA, Harvard, Vancouver, ISO, and other styles
2

Geller, James I., Pedram Argani, Adebowale Adeniran, et al. "Translocation renal cell carcinoma." Cancer 112, no. 7 (2008): 1607–16. http://dx.doi.org/10.1002/cncr.23331.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Caliò, Anna, Diego Segala, Enrico Munari, Matteo Brunelli, and Guido Martignoni. "MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge." Cancers 11, no. 8 (2019): 1110. http://dx.doi.org/10.3390/cancers11081110.

Full text
Abstract:
The new category of MiT family translocation renal cell carcinoma has been included into the World Health Organization (WHO) classification in 2016. The MiT family translocation renal cell carcinoma comprises Xp11 translocation renal cell carcinoma harboring TFE3 gene fusions and t(6;11) renal cell carcinoma harboring TFEB gene fusion. At the beginning, they were recognized in childhood; nevertheless, it has been demonstrated that these neoplasms can occur in adults as well. In the nineties, among Xp11 renal cell carcinoma, ASPL, PRCC, and SFPQ (PSF) were the first genes recognized as partners
APA, Harvard, Vancouver, ISO, and other styles
4

Kothari, KanchanS, PragatiA Sathe, LeenaP Naik, and BhuvaneshwariM Kandalkar. "Xp11 translocation renal cell carcinoma." Indian Journal of Pathology and Microbiology 56, no. 4 (2013): 471. http://dx.doi.org/10.4103/0377-4929.125383.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Neagu, O., A. Petrescu, G. Berdan, et al. "Xp11.2 translocation renal cell carcinoma." European Urology Supplements 17, no. 12 (2018): e2694. http://dx.doi.org/10.1016/s1569-9056(18)33533-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ross, Hillary, and Pedram Argani. "Xp11 translocation renal cell carcinoma." Pathology 42, no. 4 (2010): 369–73. http://dx.doi.org/10.3109/00313021003767348.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ross, Hillary, Morris Edelman, and Pedram Argani. "Xp11 Translocation Renal Cell Carcinoma." Pathology Case Reviews 15, no. 1 (2010): 3–6. http://dx.doi.org/10.1097/pcr.0b013e3181d2cfc2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

de Oliveira, C. V. L., G. R. Bechara, S. R. Zacchi, M. C. L. de Miranda, G. Z. Pinho, and M. M. L. de Miranda. "MiT family translocation renal cell carcinoma." Journal of Pediatric Surgery Case Reports 45 (June 2019): 101190. http://dx.doi.org/10.1016/j.epsc.2019.101190.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Argani, Pedram. "MiT family translocation renal cell carcinoma." Seminars in Diagnostic Pathology 32, no. 2 (2015): 103–13. http://dx.doi.org/10.1053/j.semdp.2015.02.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Torous, Vanda Farahmand, Albert Su, David Y. Lu, and Sarah M. Dry. "Adult Patient with Synchronous Gastrointestinal Stromal Tumor and Xp11 Translocation-Associated Renal Cell Carcinoma: A Unique Case Presentation with Discussion and Review of Literature." Case Reports in Urology 2015 (2015): 1–6. http://dx.doi.org/10.1155/2015/814809.

Full text
Abstract:
Gastrointestinal stromal tumor (GIST) is the most common primary mesenchymal tumor of the gastrointestinal tract. This entity comprises a wide spectrum of tumors that vary from benign to overtly malignant, with the majority of these tumors harboring oncogenic mutations of the KIT receptor tyrosine kinase that can aid in diagnosis as well as in targeted therapy. Although the majority of GISTs are sporadic, there are forms that are associated with a variety of syndromes including Carney-Stratakis syndrome and neurofibromatosis type 1, as well as a subset of familial GIST syndromes that are cause
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Translocation renal cell carcinoma"

1

Wake, Naomi Catherine. "Identification and functional analysis of a novel renal cell carcinoma (RCC) susceptibility gene from an RCC associated constitutional chromosomal translocation." Thesis, University of Birmingham, 2013. http://etheses.bham.ac.uk//id/eprint/3964/.

Full text
Abstract:
Familial renal cell carcinoma (RCC) only accounts for 3% of all RCC, yet the study of these inherited forms has provided important insights into the more common sporadic RCC. Somatic VHL inactivation is found in 70% of sporadic clear cell RCC (ccRCC) though is rarely found in other forms of RCC including papillary and chromophobe types. VHL-independent RCC tumourigenesis is poorly understood and current research involves identifying novel RCC candidate genes to further understand the mechanisms involved. In this study a constitutional balanced translocation, t(5;19)(p15.3;q12), associated with
APA, Harvard, Vancouver, ISO, and other styles
2

Malouf, Gabriel. "Décryptage des changements épigénétiques impliqués dans la transition épithélio-mésenchymateuse et le cancer." Thesis, Paris 11, 2014. http://www.theses.fr/2014PA11T037.

Full text
Abstract:
La transition épithélio-Mésenchymateuse (TEM) est un processus de plasticité cellulaire qui existe dans le développement embryonnaire et qui permet la formation des tissus et organes. Dans la cancérogénèse, ce processus est réactivé par des facteurs de transcription dont l’action implique très probablement un remodelage de la chromatine. La cartographie exacte de ces changements épigénétiques est peu connue à l’échelle du génome entier, même si il y a eu quelques études antérieures explorant les changements de quelques loci de façon bien ciblée. Ce mémoire traite du remodelage épigénétique méd
APA, Harvard, Vancouver, ISO, and other styles
3

Rashidkhani, Bahram. "Diet and renal cell carcinoma /." Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-163-6/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Fallah, Abdul Karim. "Genomic studies in renal cell carcinoma." Thesis, Manchester Metropolitan University, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.528380.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Al-Sharhan, Mouza Abdulla. "Prognostic factors in renal cell carcinoma." Thesis, University of Newcastle Upon Tyne, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.285788.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Chagnon, Fanny. "A dendritic cell vaccine for murine renal cell carcinoma." Thesis, McGill University, 2003. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=19400.

Full text
Abstract:
Renal Cell Carcinoma (RCC) has a very high rate of mortality since it does not respond to conventional therapies such as chemotherapy and radiation therapy. Furthermore, in the majority of cases, metastases are already present at the time of diagnosis. The objective of our study is to develop a noval treatment for RCC, using a dendritic cell (DC) vaccine. An animal model of RCC, RENCA, was used to develop the vaccine.
APA, Harvard, Vancouver, ISO, and other styles
7

Giraldo-Castillo, Nicolas. "The Immune Microenvironment in Clear Cell Renal Cell Carcinoma : The heterogeneous immune contextures accompanying CD8+ T cell infiltration in clear cell Renal Cell Carcinoma." Thesis, Paris 6, 2015. http://www.theses.fr/2015PA066321/document.

Full text
Abstract:
Dans cette étude, nous avons tenté de décrypter les mécanismes reliant l’augmentation de lymphocytes infiltrant les tumeurs (LIT) T CD8+ et un pronostic clinique défavorable dans le cancer du rein à cellules claires (ccRCC). Pour cela, nous avons déterminé 1) la relation entre le pronostic associé à l'expression d’immune checkpoints et l’infiltrat de cellules dendritiques (DC) et de LT CD8+ et 2) les caractéristiques phénotypiques des LIT T CD8+. L’expression des immune checkpoints a été déterminée par immunohistochimie dans une cohorte de 135 ccRCC. Nous avons constaté que les densités des ce
APA, Harvard, Vancouver, ISO, and other styles
8

Ronkainen, H. L. (Hanna-Leena). "Novel prognostic biomarkers for renal cell carcinoma." Doctoral thesis, Oulun yliopisto, 2012. http://urn.fi/urn:isbn:9789514297731.

Full text
Abstract:
Abstract Background and aims: Stage and grade are the most widely used prognostic parameters for renal cell carcinoma (RCC). The clinical course of this disease is not, however, always predictable by traditional prognostic factors. In the era of new molecular targeted therapies a more accurate prognostication of RCC patient survival is important for the individualization of treatment and follow-up of patients. Despite exhaustive research there are still no prognostic biomarkers for RCC in clinical practice. In order to find novel prognostic tissue markers for RCC, we examined the expression of
APA, Harvard, Vancouver, ISO, and other styles
9

Lawrentschuk, Nathan Leo. "Hypoxia and angiogenesis in renal cell carcinoma." Connect to thesis, 2009. http://repository.unimelb.edu.au/10187/6790.

Full text
Abstract:
Hypoxia is one of the hallmarks of cancer. It was first postulated to occur in solid tumours by Thomlinson and Gray in 1955.1 The presence of hypoxia has been demonstrated in different types of solid tumours.2 Intratumoral hypoxia is caused by the lack of functional blood vessels in proliferating tumour tissue, resulting in low intratumoral oxygen concentrations. If hypoxia is severe or prolonged, cell death occurs.3 Malignant cells can undergo genetic and adaptive changes that allow them to escape from dying of oxygen deprivation. These changes are associated with a more aggressive malignant
APA, Harvard, Vancouver, ISO, and other styles
10

Morrissey, Catherine. "The molecular pathology of renal cell carcinoma." Thesis, University of Birmingham, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.420407.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Translocation renal cell carcinoma"

1

Bukowski, Ronald M., and Andrew Novick. Renal Cell Carcinoma. Humana Press, 2000. http://dx.doi.org/10.1385/1592592295.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Campbell, Steven C., and Brian I. Rini, eds. Renal Cell Carcinoma. Humana Press, 2013. http://dx.doi.org/10.1007/978-1-62703-062-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bukowski, Ronald M., Robert A. Figlin, and Robert J. Motzer, eds. Renal Cell Carcinoma. Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-1622-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bukowski, Ronald M., Robert A. Figlin, and Robert J. Motzer, eds. Renal Cell Carcinoma. Humana Press, 2009. http://dx.doi.org/10.1007/978-1-59745-332-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Oya, Mototsugu, ed. Renal Cell Carcinoma. Springer Japan, 2017. http://dx.doi.org/10.1007/978-4-431-55531-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Figlin, Robert A., W. Kimryn Rathmell, and Brian I. Rini, eds. Renal Cell Carcinoma. Springer US, 2012. http://dx.doi.org/10.1007/978-1-4614-2400-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bukowski, Ronald M., and Andrew C. Novick, eds. Renal Cell Carcinoma. Humana Press, 2000. https://doi.org/10.1007/978-1-59259-229-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Debruyne, Frans M. J., Ronald M. Bukowski, J. Edson Pontes, and Pieter H. M. de Mulder, eds. Immunotherapy of Renal Cell Carcinoma. Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-75853-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bukowski, Ronald M., James H. Finke, and Eric A. Klein. Biology of Renal Cell Carcinoma. Springer New York, 1995. http://dx.doi.org/10.1007/978-1-4612-2536-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

M, Bukowski Ronald, Finke James H. 1944-, and Klein Eric A. 1955-, eds. Biology of renal cell carcinoma. Springer-Verlag, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Translocation renal cell carcinoma"

1

Caliò, Anna, Diego Segala, and Guido Martignoni. "MiT Family Translocation Renal Cell Carcinoma." In Encyclopedia of Pathology. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-28845-1_4847-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Caliò, Anna, Diego Segala, and Guido Martignoni. "MiT Family Translocation Renal Cell Carcinoma." In Encyclopedia of Pathology. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-41894-6_4847.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Geller, James I., Nicholas G. Cost, and Mariana M. Cajaiba. "TFE/Translocation Morphology Renal Cell Carcinoma." In Rare Kidney Tumors. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-96989-3_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Chahoud, Jad, Gabriel G. Malouf, and Nizar M. Tannir. "Translocation Renal Cell Carcinomas." In Rare Genitourinary Tumors. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-30046-7_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Pei, Xiaoru, Xin Yan, and Chen Ding. "Proteogenomic Workflow for Characterization of Microphthalmia Transcription Factor (MiT) Family Translocation Renal Cell Carcinoma." In Methods in Molecular Biology. Springer US, 2024. http://dx.doi.org/10.1007/978-1-0716-3922-1_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Russo, Paul. "Renal Cell Carcinoma." In Renal Cancer. Humana Press, 2001. http://dx.doi.org/10.1385/1-59259-144-2:003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Filippiadis, Dimitrios K., Maria Tsitskari, and Thomas D. Atwell. "Renal Cell Carcinoma." In Image-Guided Interventions in Oncology. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-48767-6_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Barker, David W., and Ronald J. Zagoria. "Renal Cell Carcinoma." In Medical Radiology. Springer Berlin Heidelberg, 2006. http://dx.doi.org/10.1007/3-540-30003-1_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Nomiya, Takuma, and Hiroshi Tsuji. "Renal Cell Carcinoma." In Carbon-Ion Radiotherapy. Springer Japan, 2013. http://dx.doi.org/10.1007/978-4-431-54457-9_28.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Garcia, Michael A., and Alexander R. Gottschalk. "Renal Cell Carcinoma." In Handbook of Evidence-Based Radiation Oncology. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-62642-0_24.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Translocation renal cell carcinoma"

1

Aziz, Maroof Abdul, Fatemeh Javadian, Sherin Susheel Mathew, et al. "Deep Learning Approach for Renal Cell Carcinoma Detection, Subtyping, And Grading." In 2024 IEEE International Conference on Image Processing (ICIP). IEEE, 2024. http://dx.doi.org/10.1109/icip51287.2024.10647236.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Melas, Marilena, Kevin J. McDonnell, Christopher K. Edlund, et al. "Abstract 491: Elucidatingde novoPATRR-mediated t(3;8) balanced translocation and clear cell renal cell carcinoma." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-491.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ku, Sheng-Yu, Swathi Ramakrishnan, Eric Ciamporcero, et al. "Abstract 2546: HDAC and Hsp90 inhibition as therapeutic strategy for translocation renal cell carcinoma." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-2546.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Damayanti, Nur P., Sreenivasulu Chintala, Ashley Orillion, et al. "Abstract 4475: Delineating translocation renal cell carcinoma oncogenesis in cells harboring TFE3 fusion with spliceosome machinery associated genes." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-4475.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Baba, Masaya, Ying Huang, Takanobu Motoshima, et al. "Abstract 3527: Clarification of the molecular mechanism for cancer development in Xp11.2 translocation renal cell carcinoma." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-3527.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Haddad, Philip A., Dalia Hammoud, and Kevin Gallagher. "Abstract 3525: Epidemiology and clinicopathology prognostic factors of TFEB translocation renal cell carcinoma (TBRCC): Analysis of updated pooled database." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-3525.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Malouf, Gabriel G., Xiaoping Su, Hui Yao, et al. "Abstract 2980: Integrated transcriptome and methylome sequencing of Xp11 translocation renal cell carcinomas reveal uncoupling of DNA methylation and transcriptional profiles." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-2980.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Dooper, Marten. "More highlights in Renal Cell Carcinoma." In ESMO Congress 2024, edited by Stefan Rauh. Medicom Medical Publishers, 2024. http://dx.doi.org/10.55788/181f901e.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ürün, Yüksel. "Fumarate hydratase–deficient renal cell carcinoma." In 2024 International Kidney Cancer Symposium. Medicom Medical Publishers, 2024. http://dx.doi.org/10.55788/0d0c70ea.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ramakrishnan, Swathi, Paula Sotomayor, Kristin Lehet, and Roberto Pili. "Abstract 5016: Epigenetics in renal cell carcinoma." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-5016.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Translocation renal cell carcinoma"

1

Ismail, Mohamed, Monish Aron, Joe Philip, and Faris Abushamma. Renal cell carcinoma – minimally invasive nephron sparing surgery. BJUI Knowledge, 2022. http://dx.doi.org/10.18591/bjuik.0114.v2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Schmidt, Laura S., and W. Marston Linehan. Principles and management of hereditary renal cell carcinoma. BJUI Knowledge, 2022. http://dx.doi.org/10.18591/bjuik.0095.v2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Drake, Richard R., and Alexander Parker. Tissue and Metabolomic Biomarkers of Recurrent Renal Cell Carcinoma. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada592797.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Stroman, Luke, and Tim O'Brien. Management of renal cell carcinoma with inferior vena cava (IVC) involvement. BJUI Knowledge, 2022. http://dx.doi.org/10.18591/bjuik.0738.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Stewart, B. J. Mass Spectrometry Data Set for Renal Cell Carcinoma and Polycystic Kidney Disease Cell Models. Office of Scientific and Technical Information (OSTI), 2017. http://dx.doi.org/10.2172/1342001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Zhou, Xiao, and Guangcheng Luo. A meta-analysis of platelet-lymphocyte ratio: a merit attention prognostic factor in renal cell carcinoma. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.9.0064.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Shen, Li. A Novel Tumor Antigen and Foxp3 Dual-Targeting Tumor Cell Vaccine Enhances the Immunotherapy in a Murine Model of Renal Cell Carcinoma. Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ada615157.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Zhou, Xiao, and Guangcheng Luo. Whether the consistency of tumor thrombus has prognostic significance in patients with renal cell carcinoma—a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.2.0015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Pareel, Vibhay, Shen Zhang, and Aldrich Ong. Stereotactic Radiation therapy in early and locally advanced inoperable renal cell carcinoma: treatment outcomes, patterns of failure and risk factors. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.3.0083.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Jin, Hongyu, and Man Zhang. Adjuvant targeted therapy combined with surgery for advanced and metastatic renal cell carcinoma: Protocol for a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.11.0093.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Translocation renal cell carcinoma' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography